# Venus Medtech to acquire Keystone Heart for undisclosed sum

Venus Medtech Inc., a Chinese transcatheter heart valve company, has signed an agreement to acquire Keystone Heart Ltd., a medical device company that makes the TriGUARD 3 cerebral embolic protection device. The acquisition gives Venus Medtech international rights to TriGUARD 3 and establishes its presence in the US and EMEA.

- Type: Acquisition
- Announced: 2020-06-17
- Status: announced
- Products: TriGUARD 3 cerebral embolic protection device, transcatheter heart valve systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Venus Medtech](https://endata.com/companies/34506.md) (acquirer)
- [Keystone Heart](https://endata.com/companies/34507.md) (target)

## Sources

- [hhmglobal.com](https://www.hhmglobal.com/knowledge-bank/news/venus-medtech-announces-agreement-to-acquire-keystone-heart-ltd), 2020-06-17: "The merger is expected to close in the fourth quarter of 2018, subject to customary closing conditions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.